Blue-Light Fundus Autofluorescence Imaging following Ruthenium-106 Brachytherapy for Choroidal Melanoma

Ophthalmologica. 2020;243(4):303-315. doi: 10.1159/000504715. Epub 2020 Jan 15.

Abstract

Purpose: To describe changes in blue-light fundus autofluorescence (FAF) and corresponding alterations in optical coherence tomography (OCT) within the irradiation field after ruthenium-106 brachytherapy (RBT) for choroidal melanoma.

Methods: Consecutive patients with choroidal melanoma were included in a retrospective case series. Patients were treated with RBT at a single institution. As part of their routine examination patients underwent multimodal imaging including ultrasonography, fundus photography, OCT, and FAF imaging (excitation = 488 nm). FAF images were analysed for changes within the irradiation field.

Results: 31 patients (mean age 65.7 years) were treated with RBT for unilateral choroidal melanoma. Mean tumour height before therapy was 2.7 mm (SD 1.0). Mean follow-up time was 23.3 months (SD 13.3). Main FAF characteristics attributable to RBT emerged as increased FAF with speckled decreased FAF (FAF mottling) within the irradiation field and a rim of increased FAF at its border. OCT scans demonstrated loss of the ellipsoid zone and the external limiting membrane, thinning of the neurosensory retina, and alterations of the retinal pigment epithelium like clumping, migration, and atrophy.

Conclusions: FAF changes in the irradiation field after RBT of choroidal melanomas follow a characteristic pattern that correlates with distinct OCT alterations. FAF and OCT imaging give additional information to monitor effects of RBT and, therefore, complement multimodal imaging techniques after plaque therapy.

Keywords: Brachytherapy; Choroidal melanoma; Fundus autofluorescence; Lipofuscin; Optical coherence tomography.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Brachytherapy / methods*
  • Choroid Neoplasms / diagnosis*
  • Choroid Neoplasms / radiotherapy
  • Female
  • Fluorescein Angiography / methods*
  • Fundus Oculi
  • Humans
  • Male
  • Melanoma / diagnosis*
  • Melanoma / radiotherapy
  • Middle Aged
  • Ophthalmoscopy / methods*
  • Retinal Pigment Epithelium / pathology*
  • Retinal Pigment Epithelium / radiation effects
  • Retrospective Studies
  • Ruthenium Radioisotopes / therapeutic use*
  • Visual Acuity

Substances

  • Ruthenium Radioisotopes
  • Ruthenium-106